Trial intelligence / Profile preview

Levetiracetam versus valproate monotherapy in newly diagnosed elderly patients with epilepsy

2004-004053-26Phase 2Terminated

Sponsor
Birthe Pedersen
Start
Feb 2005
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised, open-label trial in epilepsy comparing Levetiracetam monotherapy with Orfiril long monotherapy (2 arms). Primary endpoint: Percentage of patients seizure free during the 12 months. Started Feb 2005; status: terminated.

02

Drugs

levetiracetamOrfiril Long
03

Conditions

epilepsy

Beyond the preview

Go deeper on 2004-004053-26.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2004-004053-26.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call